Grossman Jerrold B 4

4 · ADMA BIOLOGICS, INC. · Filed Mar 8, 2023

Form 4

Period: 2023-03-06

Director

Transactions

Award
Employee Stock Option (right to buy)
2023-03-06+51,630→ 51,630 total
Exercise: $3.35Exp: 2033-03-06→ Common Stock (51,630 underlying)
Award
Common Stock
2023-03-06+25,815→ 313,265 total

Holdings

Footnotes (7)

[F1]These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date.
[F2]Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 13,293 RSUs granted on March 7, 2022, which will vest in full on March 7, 2023; and (iii) 274,157 shares of common stock owned by the reporting person.
[F3]These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
[F4]These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
[F5]These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
[F6]These shares are owned by the reporting person's wife.
[F7]The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.

Documents

1 file